Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

XERO LIMITED Director's Dealing 2017

Feb 22, 2017

66106_rns_2017-02-22_c4934f4d-ce94-4648-b9fd-f86e10742ec1.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

DocuSign Envelope ID: AF60E55C-423E-40FD-B993-38961E749E68

==> picture [79 x 21] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: Xero Limited(XRO)
Date this disclosure made: 23 February2017
Date of last disclosure: 17 February2017
Director or senior managergiving disclosure
Full name(s): Christopher Pell Liddell
(Chris Liddell)
Name of listed issuer: Xero Limited(XRO)
Name of related body corporate (if applicable): Not applicable
Position held in listed issuer: Ceased role as Director on
20 January 2017
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: (a) Ordinary shares in Xero
Limited (Ordinary Shares);
(b) Unlisted options to
subscribe for Ordinary
Shares (Options)
Nature of the affected relevant interest(s): (a) Legal ownership of
Ordinary Shares; (b) Holder
of Options to subscribe for
Ordinary Shares (each
Option entitling the holder to
subscribe for one Ordinary
Share subject to the terms of
the Xero Limited (USA)
Equity Incentive Scheme) (US
Plan)
For that relevant interest-
Number held in class before acquisition or disposal: (a) None; (b) 147,556
Number held in class after acquisition or disposal: (a) 21,491; (b) None
Current registered holder(s): (a) Not applicable; (b) Chris
Liddell
Registered holder(s) once transfers are registered: (a) Chris Liddell; (b) Not
applicable
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: Not applicable
Class of underlyingfinancial products: Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products
(if any):
Not applicable
A statement as to whether the derivative is cash settled or physicallysettled: Not applicable
Maturitydate of the derivative(if any): Not applicable
Expirydate of the derivative(if any): Not applicable
Theprice specified in the terms of the derivative(if any): Not applicable
Any other details needed to understand how the amount of the consideration payable under the
derivative or the value of the derivative is affected by the value of the underlying financial
products:
Not applicable
_For that derivative,- _
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the relevant interest
in the derivative:
Not applicable
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 5
Details of transactions requiring disclosure-
Date oftransaction: Transactions took place on:
(i) 17 February 2017; (ii) 17
February 2017; (iii)
Numerous on-market
transactions on 20 February
2017 with settlement
occurring on 22 February
2017; (iv) Numerous on-
market transactions on 21
February 2017 with
settlement occurring on 23
February 2017; (v) Numerous
on-market transactions on 22
February 2017 with
settlement occurring on 24
February 2017

DocuSign Envelope ID: AF60E55C-423E-40FD-B993-38961E749E68

Nature oftransaction: (i) 33,746 Ordinary Shares
were issued to Chris Liddell
upon exercise of Options by
Chris Liddell granted under
the US Plan; (ii) Forfeiture of
remaining 113,810 Options
held by Chris Liddell in
connection with Chris
Liddell's cessation of his role
as Director of Xero Limited;
(iii) On-market disposal of
1,134 Ordinary Shares; (iv)
On-market disposal of 5,390
Ordinary Shares; (v) On-
market disposal of 5,731
OrdinaryShares
(i) 33,746 Ordinary Shares
were issued to Chris Liddell
upon exercise of Options by
Chris Liddell granted under
the US Plan; (ii) Forfeiture of
remaining 113,810 Options
held by Chris Liddell in
connection with Chris
Liddell's cessation of his role
as Director of Xero Limited;
(iii) On-market disposal of
1,134 Ordinary Shares; (iv)
On-market disposal of 5,390
Ordinary Shares; (v) On-
market disposal of 5,731
OrdinaryShares
Name ofany otherparty orparties to the transaction(if known): (i) Not applicable; (ii) Not
applicable; (iii) Not known (on-
market disposal); (iv) Not
known (on-market disposal);
(v) Not known (on-market
disposal)
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or
disposal. If the consideration was not in cash and cannot be readily by converted into a cash
value, describe the consideration:
(i) NZ$542,937.88 for the
exercise of 21,442 Options at
an exercise price of
NZ$16.14 per Option and
12,304 Options at an
exercise price of NZ$16.00
per Option; (ii) N/A. Forfeiture
of 113,810 Options held by
Chris Liddell in connection
with Chris Liddell's cessation
of his role as Director of Xero
Limited; (iii) 1,134 Ordinary
Shares were disposed of at
an average price of
AU$17.8361 per share
(ranging from AU$17.75 to
AU$17.85 per share); (iv)
5,390 Ordinary Shares were
disposed of at an average
price of AU$17.5526 per
share (ranging from
AU$17.50 to AU$17.70 per
share); (v) 5,731 Ordinary
Shares were disposed of at
an average price of
AU$17.5243 per share
(ranging from AU$17.48 to
AU$17.62 per share)
Numberof financialproducts towhichthe transaction related: 2
If the issuer has a financial products trading policy that prohibits directors or senior managers
from trading during any period without written clearance (a closed period) include the following
details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period: Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal to proceed
duringthe closedperiod:
Not applicable
Date of the prior written clearance(if any): Not applicable
Summary of other relevant interests after acquisition or disposal:
Class ofquotedfinancialproducts:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Currentregisteredholder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products
(if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled: Not applicable
Maturity date of the derivative (if any): Not applicable
Expiry date of the derivative (if any): Not applicable
The price's specified terms (if any): Not applicable
Any other details needed to understand how the amount of the consideration payable under the
derivative or the value of the derivative is affected by the value of the underlying financial
products:
Not applicable
For that derivative relevant interest,-
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the relevant interest
in the derivative:
Not applicable
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is
correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
23 February 2017 (NZT)
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is
correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature: 23 February 2017 (NZT)